Bluestein R H & CO LLC Edwards Lifesciences Corp Transaction History

Bluestein R H & CO LLC

$1.61 Billion
Q3 2022

A detailed history of Bluestein R H & CO LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bluestein R H & CO LLC holds 204,527 shares of EW stock, worth $13.9 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares

204,527

Previous 203,647 0.43%

Holding current value

$13.9 Million

Previous $19.4 Million 12.73%

% of portfolio

1.05%

Previous 1.19%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $72,485 - $94,415	880 Added 0.43%	204,527 $16.9 Million
Q2 2022 Aug 11, 2022	BUY	$86.5 - $128.27 $86,067 - $127,628	995 Added 0.49%	203,647 $19.4 Million
Q1 2022 May 11, 2022	SELL	$101.96 - $128.34 $474,317 - $597,037	-4,652 Reduced 2.24%	202,652 $23.9 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $9.22 Million - $11.3 Million	86,688 Added 71.87%	207,304 $26.9 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $9.34 Million - $11.1 Million	90,742 Added 303.75%	120,616 $13.7 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $493,901 - $617,141	-5,891 Reduced 16.47%	29,874 $3.09 Million
Q1 2021 May 12, 2021	BUY	$78.68 - $90.67 $21,243 - $24,480	270 Added 0.76%	35,765 $2.99 Million
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $68,463 - $87,124	-955 Reduced 2.62%	35,495 $3.24 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $1.09 Million - $1.42 Million	16,190 Added 79.91%	36,450 $2.91 Million
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $769,885 - $1.03 Million	13,380 Added 194.48%	20,260 $1.4 Million
Q1 2020 May 12, 2020	SELL	$52.41 - $81.0 $8.9 Million - $13.8 Million	-169,798 Reduced 96.11%	6,880 $1.3 Million
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $563,848 - $645,555	7,864 Added 4.66%	176,678 $41.2 Million
Q3 2019 Nov 13, 2019	BUY	$61.55 - $75.43 $354,958 - $435,004	5,767 Added 3.54%	168,814 $37.1 Million
Q2 2019 Aug 12, 2019	SELL	$55.74 - $64.41 $1.48 Million - $1.71 Million	-26,568 Reduced 14.01%	163,047 $30.1 Million
Q1 2019 May 10, 2019	SELL	$47.89 - $64.05 $9.47 Million - $12.7 Million	-197,679 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $575,623 - $706,226	-12,403 Reduced 5.9%	197,679 $30.3 Million
Q3 2018 Nov 13, 2018	BUY	$45.7 - $58.03 $2.54 Million - $3.22 Million	55,498 Added 35.9%	210,082 $36.6 Million
Q2 2018 Aug 10, 2018	BUY	$42.45 - $51.3 $3.18 Million - $3.84 Million	74,820 Added 93.8%	154,584 $22.5 Million
Q1 2018 May 10, 2018	BUY	$37.19 - $47.45 $2.83 Million - $3.61 Million	76,089 Added 2070.45%	79,764 $11.1 Million
Q4 2017 Feb 13, 2018	SELL	$33.79 - $39.39 $128,064 - $149,288	-3,790 Reduced 50.77%	3,675 $414,000
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $270,904 - $289,865	7,465	7,465 $816,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluestein R H & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluestein R H & CO LLC with notifications on news.

Account

Bluestein R H & CO LLC Edwards Lifesciences Corp Transaction History